Amyris Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Amyris.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Chemicals earnings growth	15.0%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

Recent updates

What Does Amyris, Inc.'s (NASDAQ:AMRS) Share Price Indicate?

Apr 12

Does This Valuation Of Amyris, Inc. (NASDAQ:AMRS) Imply Investors Are Overpaying?

Mar 22

At US$2.95, Is Amyris, Inc. (NASDAQ:AMRS) Worth Looking At Closely?

Oct 31

Amyris Cost Breakdown

Oct 07

Recurring Marketing Exclusivity Deals Accelerate Amyris On Path To Profitability

Oct 01

Are Investors Undervaluing Amyris, Inc. (NASDAQ:AMRS) By 43%?

Sep 02

Amyris: In Dire Need For Additional Capital

Aug 22

Amyris, Inc. (NASDAQ:AMRS) Just Reported, And Analysts Assigned A US$10.91 Price Target

Aug 12

Amyris' Vertically-Integrated Business Model Transitioning From Investment Mode To Payoff Mode

Aug 08

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Amyris has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OTCPK:AMRS.Q - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2023	268	-615	-540	-463	N/A
12/31/2022	270	-529	-632	-526	N/A
9/30/2022	259	-341	-700	-575	N/A
6/30/2022	236	-213	-623	-511	N/A
3/31/2022	223	-89	-519	-442	N/A
12/31/2021	342	-270	-227	-181	N/A
9/30/2021	357	-417	-74	-49	N/A
6/30/2021	343	-467	-48	-35	N/A
3/31/2021	321	-585	-35	-21	N/A
12/31/2020	173	-382	-189	-176	N/A
9/30/2020	134	-351	-223	-209	N/A
6/30/2020	135	-325	-222	-209	N/A
3/31/2020	167	-293	-177	-166	N/A
12/31/2019	153	-270	-170	-157	N/A
9/30/2019	128	-240	-149	-133	N/A
6/30/2019	108	-258	-127	-113	N/A
3/31/2019	60	-202	-135	-121	N/A
12/31/2018	64	-223	-122	-109	N/A
9/30/2018	112	-287	-98	-88	N/A
6/30/2018	122	-253	-104	-95	N/A
3/31/2018	133	-250	-106	-101	N/A
12/31/2017	128	-202	-106	-101	N/A
9/30/2017	85	-139	-140	-140	N/A
6/30/2017	87	-116	-104	-104	N/A
3/31/2017	71	-119	-85	-84	N/A
12/31/2016	67	-97	N/A	-82	N/A
9/30/2016	55	-94	N/A	-78	N/A
6/30/2016	37	-151	N/A	-91	N/A
3/31/2016	35	-185	N/A	-106	N/A
12/31/2015	34	-222	N/A	-85	N/A
9/30/2015	36	-118	N/A	-73	N/A
6/30/2015	44	-78	N/A	-82	N/A
3/31/2015	45	-66	N/A	-78	N/A
12/31/2014	43	2	N/A	-85	N/A
9/30/2014	47	-195	N/A	-101	N/A
6/30/2014	38	-183	N/A	-96	N/A
3/31/2014	39	-186	N/A	-92	N/A
12/31/2013	41	-235	N/A	-106	N/A
9/30/2013	32	-139	N/A	-101	N/A
6/30/2013	44	-135	N/A	-105	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if AMRS.Q's forecast earnings growth is above the savings rate (2.4%).

Earnings vs Market: Insufficient data to determine if AMRS.Q's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if AMRS.Q's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if AMRS.Q's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if AMRS.Q's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if AMRS.Q's Return on Equity is forecast to be high in 3 years time

Amyris Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Consensus EPS estimates upgraded to US$0.75 loss

Price target increased by 9.0% to US$3.40

No longer forecast to breakeven

Price target decreased by 8.2% to US$3.12

No longer forecast to breakeven

No longer forecast to breakeven

Recent updates

Amyris, Inc. announced delayed annual 10-K filing

Third Amended Joint Reorganization Plan Filed by Amyris, Inc.

Foris Ventures Provides Information to the Shareholders

Amyris, Inc. Announces Resignation of Elizabeth Dreyer as Chief Accounting Officer and Corporate Controller, Effective as of January 2, 2024

Amyris, Inc. announced delayed 10-Q filing

Nasdaq to Delist the Common Stock of Amyris

Amyris, Inc. Appoints Scott White as A Class II Director

Motion for Joint Administration Filed by Amyris, Inc.

Amyris' Common Stock To Be Delisted from Nasdaq

Amyris, Inc. announced delayed 10-Q filing

Amyris, Inc. Filed for Bankruptcy

Amyris, Inc. Announces Executive Changes

Amyris Receives Deficiency Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement

First quarter 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates upgraded to US$0.75 loss

Price target increased by 9.0% to US$3.40

What Does Amyris, Inc.'s (NASDAQ:AMRS) Share Price Indicate?

Does This Valuation Of Amyris, Inc. (NASDAQ:AMRS) Imply Investors Are Overpaying?

Full year 2022 earnings: EPS and revenues miss analyst expectations

No longer forecast to breakeven

Price target decreased by 8.2% to US$3.12

Amyris Launches 4U by Tia™ Haircare Line Exclusively At Walmart

Amyris, Inc. announced that it expects to receive $20.000001 million in funding from Foris Ventures, LLC

Amyris, Inc. Announces Executive Changes

No longer forecast to breakeven

No longer forecast to breakeven

Forecast to breakeven in 2024

Amyris, Inc. Provides Financial Guidance for the Fourth Quarter of 2022

Price target decreased to US$9.31

Amyris, Inc. to Report Q3, 2022 Results on Nov 08, 2022

At US$2.95, Is Amyris, Inc. (NASDAQ:AMRS) Worth Looking At Closely?

Amyris, Inc. Launches Two New Consumer Brands

Amyris, Inc. Announces Three of Its Consumer Brands Will Be Included in Sephora's Launch in the United Kingdom

Amyris Cost Breakdown

Recurring Marketing Exclusivity Deals Accelerate Amyris On Path To Profitability

Elizabeth Dreyer Joins Amyris, Inc. as Chief Accounting Officer & Corporate Controller, Effective October 11, 2022

CFO & Chief Administration Officer recently sold US$74k worth of stock

Are Investors Undervaluing Amyris, Inc. (NASDAQ:AMRS) By 43%?

Amyris: In Dire Need For Additional Capital

President recently bought US$69k worth of stock

Amyris, Inc. (NASDAQ:AMRS) Just Reported, And Analysts Assigned A US$10.91 Price Target

Price target decreased to US$10.91

Forecast to breakeven in 2024

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Amyris, Inc. Provides Revenue Guidance for 2022

Amyris' Vertically-Integrated Business Model Transitioning From Investment Mode To Payoff Mode

Amyris, Inc. to Report Q2, 2022 Results on Aug 09, 2022

President recently sold US$118k worth of stock

Amyris: Revenues Need To Catch Expenses

Chief Legal Officer & Secretary notifies of intention to sell stock

Amyris, Inc. Announces Executive Changes Effective June 17, 2022

CFO & Chief Administration Officer recently sold US$82k worth of stock

High number of new directors

Amyris, Inc., Annual General Meeting, Jun 10, 2022

Amyris: Elevated Cash Usage Causes Investors To Head For The Exits

Amyris, Inc. to Report Q1, 2022 Results on May 10, 2022

Amryis Update: Building Value One Brick At A Time

Amyris, Inc. (NasdaqGS:AMRS) entered into an Agreement and Plan of Merger and Reorganization to acquire Onda Beauty Inc.

Amyris, Inc. (NasdaqGS:AMRS) entered into an Agreement and Plan of Merger and Reorganization to acquire Onda Beauty Inc.

Amyris, Inc., Annual General Meeting, May 27, 2022

Amyris: JVN Could Be Their Most Valuable Brand Yet

Amyris, Inc. announced delayed annual 10-K filing

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies